ARTICLE | Distillery Therapeutics
Endocrine / Metabolic
November 15, 2016 5:40 PM UTC
Cell culture and mouse studies identified a non-acidic sulfonamide-based GPR120 agonist that could help treat insulin resistance in obesity. Chemical synthesis and testing of non-acidic sulfonamide an...
BCIQ Company Profiles
BCIQ Target Profiles